Ferran Fece de la Cruz
Massachusetts General Hospital Cancer Center
4 papers found
Refreshing results…
Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers
UploadLandscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma
UploadVertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
Download from aacrjournals.orgMissing publications? Search for publications with a matching author name.